WallStreetZenWallStreetZen

NASDAQ: ICLR
Icon PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ICLR

Based on 12 analysts offering 12 month price targets for Icon PLC

Min Forecast
$150.00-11.41%
Avg Forecast
$179.92+6.26%
Max Forecast
$209.00+23.44%

Should I buy or sell ICLR stock?

Based on 12 analysts offering ratings for Icon PLC.

Buy
Strong Buy
2 analysts 16.67%
Buy
5 analysts 41.67%
Hold
4 analysts 33.33%
Sell
1 analysts 8.33%
Strong Sell
0 analysts 0%
Although ICLR's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ICLR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their ICLR stock forecasts and price targets.

ICLR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-31
lockedlocked$00.00+00.00%2026-07-31
lockedlocked$00.00+00.00%2026-06-26
lockedlocked$00.00+00.00%2026-06-25
lockedlocked$00.00+00.00%2026-06-25
Barclays
Top 7%
94
HoldMaintains$175.00+3.36%2026-06-25
RBC Capital
Top 46%
55
BuyUpgrades$185.00+9.27%2026-06-25
TD Cowen
Top 27%
74
Strong BuyMaintains$197.00+16.35%2026-06-25
JP Morgan
Top 20%
81
HoldMaintains$155.00-8.45%2026-06-25
Evercore ISI Group
Top 20%
81
BuyMaintains$180.00+6.31%2026-06-25

1 of 2

Forecast return on equity

Is ICLR forecast to generate an efficient return?

Company
12.35%
Industry
350.47%
Market
167.94%
ICLR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ICLR forecast to generate an efficient return on assets?

Company
7.06%
Industry
14.61%
ICLR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ICLR earnings per share forecast

What is ICLR's earnings per share in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$10.80+151.78%
Avg 2 year Forecast
$12.11+182.4%
Avg 3 year Forecast
$13.60+217.04%
ICLR's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ICLR revenue forecast

What is ICLR's revenue in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$8.3B+0.37%
Avg 2 year Forecast
$8.6B+4.45%
Avg 3 year Forecast
$9.1B+9.84%
ICLR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ICLR earnings growth forecast

How is ICLR forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
46.77%
Industry
18.76%
Market
30.83%
ICLR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ICLR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ICLR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ICLR revenue growth forecast

How is ICLR forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
3.09%
Industry
7.59%
Market
13.23%
ICLR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ICLR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ICLR vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
ICLR$169.31$179.92+6.26%Buy
CRL$278.26$272.63-2.03%Strong Buy
RVTY$124.31$119.64-3.76%Buy
MEDP$587.52$580.88-1.13%Hold
QGEN$42.50$43.50+2.35%Buy
View Top Diagnostic & Research Stocks

Icon Stock Forecast FAQ

Is Icon Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NASDAQ: ICLR) stock is to Buy ICLR stock.

Out of 12 analysts, 2 (16.67%) are recommending ICLR as a Strong Buy, 5 (41.67%) are recommending ICLR as a Buy, 4 (33.33%) are recommending ICLR as a Hold, 1 (8.33%) are recommending ICLR as a Sell, and 0 (0%) are recommending ICLR as a Strong Sell.

If you're new to stock investing, here's how to buy Icon stock.

What is ICLR's earnings growth forecast for 2026-2028?

(NASDAQ: ICLR) Icon's forecast annual earnings growth rate of 46.77% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 18.76%, and it is also forecast to beat the US market's average forecast earnings growth rate of 30.83%.

Icon's earnings in 2026 is $328,882,000.On average, 20 Wall Street analysts forecast ICLR's earnings for 2026 to be $833,365,758, with the lowest ICLR earnings forecast at $782,876,043, and the highest ICLR earnings forecast at $879,789,445. On average, 20 Wall Street analysts forecast ICLR's earnings for 2027 to be $934,707,811, with the lowest ICLR earnings forecast at $822,649,038, and the highest ICLR earnings forecast at $1,058,015,668.

In 2028, ICLR is forecast to generate $1,049,382,112 in earnings, with the lowest earnings forecast at $885,406,272 and the highest earnings forecast at $1,192,495,454.

What is ICLR's revenue growth forecast for 2026-2028?

(NASDAQ: ICLR) Icon's forecast annual revenue growth rate of 3.09% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.23%.

Icon's revenue in 2026 is $8,252,814,000.On average, 20 Wall Street analysts forecast ICLR's revenue for 2026 to be $639,068,313,147, with the lowest ICLR revenue forecast at $605,274,769,605, and the highest ICLR revenue forecast at $670,238,613,583. On average, 20 Wall Street analysts forecast ICLR's revenue for 2027 to be $665,069,281,580, with the lowest ICLR revenue forecast at $624,331,859,228, and the highest ICLR revenue forecast at $719,077,227,880.

In 2028, ICLR is forecast to generate $699,402,904,585 in revenue, with the lowest revenue forecast at $653,187,533,394 and the highest revenue forecast at $744,306,654,223.

What is ICLR's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ICLR) forecast ROA is 7.06%, which is lower than the forecast US Diagnostics & Research industry average of 14.61%.

What is ICLR's Price Target?

According to 12 Wall Street analysts that have issued a 1 year ICLR price target, the average ICLR price target is $179.92, with the highest ICLR stock price forecast at $209.00 and the lowest ICLR stock price forecast at $150.00.

On average, Wall Street analysts predict that Icon's share price could reach $179.92 by Jul 31, 2027. The average Icon stock price prediction forecasts a potential upside of 6.26% from the current ICLR share price of $169.31.

What is ICLR's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ICLR) Icon's current Earnings Per Share (EPS) is $4.29. On average, analysts forecast that ICLR's EPS will be $10.80 for 2026, with the lowest EPS forecast at $10.15, and the highest EPS forecast at $11.40. On average, analysts forecast that ICLR's EPS will be $12.11 for 2027, with the lowest EPS forecast at $10.66, and the highest EPS forecast at $13.71. In 2028, ICLR's EPS is forecast to hit $13.60 (min: $11.48, max: $15.46).

What is ICLR's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ICLR) forecast ROE is 12.35%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.